SlidesetRSVHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019ELEVATED FECAL INFLAMMATORY BIOMARKERS IN HIV-/+ MSM ASSOCIATE WITH GUT MICROBIOTA - Jennifer SchneiderView Slideset
SlidesetRSVHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019Host Genetic Determinants of the Vaginal Microbiome and Bacterial Vaginosis in Kenyan Women - Supriya MehtaView Slideset
SlidesetRSVHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019Glycomic Determinants of Gut Microbial Dysbiosis and Translocation During Suppressed HIV Infection - Leila GironView Slideset
SlidesetRSVHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019Regulation of intestinal viral infections by the microbiota - Megan Baldridge, MD, PhDView Slideset
SlidesetRSVHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019Host-microbiome interactions at the oral mucosal barrier - Niki Moutsopoulos, DDS, PhDView Slideset
NvENielka van ErpPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Drug - Food Interaction an Unrealized Potential - Nielka van Erp, PharmD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Correlation Between Sunitinib Exposure and Toxicity in a Real-life Patient Cohort - Kim WesterdijkView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib - Koen HussaartView Slideset
SKStijn KoolenPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhDView Slideset
NSNeeltje SteeghsMD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Dose Individualization Potential for Oral Targeted Oncolytics - Neeltje Steeghs, MD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan - Ruben van EerdenView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients - Félicien Le LouedecView Slideset
